Why Novel Nanoparticle-based Delivery Platforms Hold Key for HIV/AIDS Treatment and Prevention?

Journal Title: HIV/AIDS Research and Treatment – Open Journal - Year 2016, Vol 2, Issue 3

Abstract

The administration of highly active antiretroviral therapy (HAART) to HIV/AIDS patients has greatly reduced their morbidity and mortality. However, HAART regimens have myriad of limitations, which make it difficult to completely eradicate HIV/AIDS from the body. Cells harboring latent HIV reside in restricted areas in the body: cellular and anatomical reservoirs. The residing of HIV in these restricted sanctuaries makes HAART regimens incapable of completely eliminating HIV from the body. In addition, HAART regimens have to be taken for a lifetime making AIDS patients develop resistance to the drugs. When HIV/AIDS patients take HAART regimens overtime, the drugs result in side effects, such as drug toxicities and treatment fatigue. The development of nanotechnology has revolutionized medicine today. Nanotechnology have the potential to mitigate the challenges that doctors and scientists are facing with the current treatment and prevention of HIV/AIDS. In this review, I discuss the challenges of HAART regimens and how the novel nanoparticle-based delivery platforms can be advanced for HIV/AIDS treatment and prevention.

Authors and Affiliations

Michael Ochieng Otieno

Keywords

Related Articles

Determination on the Expression of Activated RANTES G 28 in HIV-1 Infection and in Co Infection with Hepatitis B Virus and Hepatitis C Virus and Its Effect on Leukocytes

Human Immunodeficiency Virus (HIV), coinfected with hepatitis B virus and hepatitis C virus challenges the immune system. Regulated on activation normal T cell expressed and secreted (RANTES) is one of the natural ligand...

It’s Time to Examine the Impact of Genetic Susceptibility on the Incidence of Diabetes among HIV-Infected Individuals

The remarkable advances in application of anti-retroviral therapy (ART) to treat HIVinfection has had a profound impact on the HIV epidemic as well as improved the quality and longevity of life for those who receive such...

Homelessness, Mental Illness, Substance Abuse, and HIV: An Insidious Syndemic

Background: This cross-sectional study examined the effects of face-to-face (real) and virtual social support networks on the mental health status of Japanese HIV-positive males. Method: A nationwide online cross-section...

The HIV-2 SU Glycoprotein Influence Proviral Integration Dynamics into Human CD4+ T-Lymphocytes

Primary and chimeric Human Immunodeficiency Virus type 2 (HIV-2), co-receptor usage, cDNA integration and, pathogenesis are mechanisms still poorly understood. However, these features seem to be related to a flexible env...

Relationship between Knowledge of Someone Infected With HIV/AIDS and HIV Stigma: A Moderated Mediation Model of HIV Knowledge, Gender and HIV Test Uptake

Introduction: Sub-Saharan Africa has been particularly impacted by the HIV epidemic with an estimated 24.7 million out of 36.9 million people living with HIV/AIDS (PLWH). Nigeria has the second highest number of people l...

Download PDF file
  • EP ID EP555290
  • DOI 10.17140/HARTOJ-2-113
  • Views 124
  • Downloads 0

How To Cite

Michael Ochieng Otieno (2016). Why Novel Nanoparticle-based Delivery Platforms Hold Key for HIV/AIDS Treatment and Prevention?. HIV/AIDS Research and Treatment – Open Journal, 2(3), 81-85. https://europub.co.uk/articles/-A-555290